This Senior Director will lead the U.S. advocacy strategy for Gilead's Oncology portfolio with a primary focus on late-stage assets.
Base: Bay Area $243,100-$314,600; Other US $221,000-$286,000; Bonus/Equity: Discretionary annual bonus and stock-based long-term incentives available
Must-have
Nice-to-have
Not specified